Tags : Sophie Holdt

Pharma

Vifor Pharma divestment of finished drug product manufacturing business

Vifor Pharma Group closed its divestment transaction regarding its finished drug product manufacturing business with facilities in Fribourg, Ettingen (both in Switzerland) and Lisbon (Portugal) to CordenPharma, a full-service Contract Development & Manufacturing Organisation (CDMO) of APIs, Excipients, Drug Products, and associated Packaging services. The Vifor Pharma Group is a global pharmaceutical company aiming to […]

Deal & transactions

Katadyn Group acquired by a group of entre­pren­eurs led by Kontivia

Katadyn Group, a Swiss-based spe­cial­ist in port­able water fil­ters and trekking food, has been acquired by a group of entre­pren­eurs led by Kontivia, a long-term, down-to-earth investment company and invests together with selected entrepreneurial families in established medium- sized companies in Switzerland and southern Germany. The acquisition was consummated through Bifolia Holding which was renamed in Katadyn Group following the closing of the transaction.  The majority shareholder of Katadyn Holding, Adrian Schmassmann, and […]

Deal & transactions

Helix Acquisition Corp business agreement with MoonLake. The advisors

Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At closing of the envisaged business combination, MoonLake will have access to approximately USD 230 million in cash (subject to redemptions), […]

Banking & Finance

MoonLake Immunotherapeutics closes Series A Funding Round – The Advisors

MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseaseshas closed a Series A financing round, lead by BVF Partners LP. Other investors included Merck KGaA, Darmstadt, Germany. MoonLake Immunotherapeutics was established by an international team of immunology specialists to create next-level therapies for inflammatory skin and joint […]